Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-stage Small Cell Lung Cancer, LS-SCLC”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Large-scale testing (Phase 3)Looking for participantsNCT06095583
What this trial is testing

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Shanghai Junshi Bioscience Co., Ltd. 756
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07538258
What this trial is testing

Benmelstobart Plus Anlotinib, Chemotherapy and Thoracic Radiation for Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Yayi He 27
Not applicableLooking for participantsNCT06869239
What this trial is testing

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Peking University Cancer Hospital & Institute 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381543
What this trial is testing

Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone

Who this might be right for
Localized Small Cell Lung Cancer
Peking University Cancer Hospital & Institute 76
Testing effectiveness (Phase 2)Looking for participantsNCT07091305
What this trial is testing

QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)ChemoradiotherapyInduction Therapy+1 more
Shanghai Chest Hospital 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07559786
What this trial is testing

A Multicenter, Randomized, Cohort, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

Who this might be right for
SCLC, Limited Stage
Henan Cancer Hospital 200
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06773156
What this trial is testing

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Second Affiliated Hospital of Nanchang University 37
Not applicableLooking for participantsNCT07309211
What this trial is testing

Durvalumab as Consolidation Therapy in Patients With LS-SCLC Following sCRT

Who this might be right for
SCLC, Limited Stage
The First Affiliated Hospital with Nanjing Medical University 25
Large-scale testing (Phase 3)Looking for participantsNCT07008716
What this trial is testing

Omitting CTV for Primary Tumor in LS-SCLC

Who this might be right for
SCLC, Limited StageRadiation ExposureRadiotherapy Side Effect+1 more
Sun Yat-sen University 852
Post-approval studies (Phase 4)Not Yet RecruitingNCT07485920
What this trial is testing

A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
The Affiliated Hospital of Qingdao University 20
Testing effectiveness (Phase 2)Looking for participantsNCT07055581
What this trial is testing

Durvalumab as Consolidation for Patients LS-SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Qian Chu 100
Testing effectiveness (Phase 2)UnknownNCT04647357
What this trial is testing

A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer, LS-SCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Large-scale testing (Phase 3)UnknownNCT04691063
What this trial is testing

The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.

Who this might be right for
Small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 486
Testing effectiveness (Phase 2)Looking for participantsNCT06773910
What this trial is testing

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

Who this might be right for
Limited Stage Small Cell Lung Cancer
SCRI Development Innovations, LLC 250
Testing effectiveness (Phase 2)Looking for participantsNCT06911606
What this trial is testing

Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)

Who this might be right for
SCLC, Limited Stage
Guangdong Provincial People's Hospital 45
Large-scale testing (Phase 3)Looking for participantsNCT05623267
What this trial is testing

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

Who this might be right for
Limited Stage Small Cell Lung Cancer
Sun Yat-sen University 346
Testing effectiveness (Phase 2)Looking for participantsNCT06295926
What this trial is testing

Serplulimab Combined With CCRT for LS-SCLC.

Who this might be right for
Small Cell Lung Cancer
Peking Union Medical College Hospital 96
Large-scale testing (Phase 3)Active Not RecruitingNCT06117774
What this trial is testing

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Who this might be right for
Limited Stage Small Cell Lung CancerSmall Cell Lung Cancer
Amgen 404
Testing effectiveness (Phase 2)Looking for participantsNCT06719700
What this trial is testing

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Who this might be right for
ToripalimabSurufatinibChemoradiotherapy+1 more
Sun Yat-sen University 47
Large-scale testing (Phase 3)Active Not RecruitingNCT03703297
What this trial is testing

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Who this might be right for
Small Cell Lung Cancer
AstraZeneca 730
Load More Results